About the company
Servier is a global pharmaceutical group governed by a nonprofit foundation, committed to making a meaningful social impact for patients and contributing to a sustainable world. The Group’s unique governance model ensures its independence while fostering long-term innovation, with 100% of its profits reinvested in the company’s development. As a world leader in cardiometabolism and venous diseases, Servier drives transformative innovation in chronic conditions through a holistic approach, making patient adherence a priority across the globe. Its ambition is to become a leading player in rare cancers, which is why the Group invests heavily in oncology, allocating close to 70% of its R&D budget to this field. Headquartered in France, Servier operates in close to 140 countries. In 2023-2024, the Group, which employs over 22,000 people worldwide, achieved sales revenue of €5.9 billion.
In Ukraine Servier operates 25 years.
Life at company
Ranking
| List | Ranking position |
|---|---|
| World Top Workplaces 2025 | #5 |
| Top Workplaces in Ukraine 2025 | #2 |
| Top Workplaces in Europe 2025 | #2 |
| Top Workplaces in Europe 2021 | #4 |
Certification details
Overall employee experience score
Results overview
Quotes from the team
At Servier Ukraine, we have always believed that our success reflects our people’s spirit. Being certified as a Best Place to Work once again is not just an award; it is a testament to the trust, resilience, and passion that define our team. Together, as one Team, we are building more than a workplace; we are fostering a community united by a shared purpose: to improve the lives of patients. This recognition inspires us to continue nurturing a culture where every individual is empowered to grow and make a meaningful impact on society.
Benjamin Abdili
General Manager
